Platelet dysfunction

Platelets Disorders
Dr. N. Singh, Dr. O. Ingaramo, Dr. S. Manuel
http://www.ttuhsc.edu/

Evaluating the Evidence Behind the Surgical Treatment of Lumbar Stenosis
Joseph Beshay, MD
http://neurosurgery.uthscsa.edu/

Disorders of platlets and blood vessels
http://instructional1.calstatela.edu/

Laboratory Diagnosis of Bleeding Disorders
http://www.cumc.columbia.edu/

Bleeding Evaluation of the Bleeding Patient
http://www.medicine.wisc.edu/

Basic Clinician Training - Hemorrhagic States
http://www.medicine.wisc.edu

Case Conference
Vincent Chen
http://www.ent.uci.edu/

Blood Administration
http://www.austincc.edu/

Paris-Trousseau platelets: a manifestation of Jacobsen syndrome
Interesting Case by Shubnum Chaudhery
http://www.georgiahealth.edu/

Lymphoproliferative Disorders
http://www.hawaii.edu/

Perioperative management of antiplatelet therapy in patients with coronary artery stents
Esi Rhett, MD, Davide Cattano, MD PhD
http://www.uth.tmc.edu/

Hematology
Jan Bazner-Chandler
http://home.apu.edu/

Lassa Fever
http://www.tropical.umn.edu

Perioperative Management of Liver Transplant Patients
Geoffrey Schultz, MD
http://scalpel.stanford.edu/

An Evidence Based Approach to Transfusion
Terry Gernsheimer, MD
http://staff.washington.edu

Hematologic Disorders
http://www.mac.edu/

Clinical Manifestations of Bleeding Disorders
http://www.austincc.edu/

Blood Administration
Lisa Randall
http://www.austincc.edu/

Pediatric Hematology Board Review
Lakshmi Venkateswaran MD
http://www.bcm.edu/

292 Published articles list

1. Hypothermia-induced reversible platelet dysfunction.
2. PFA-100 system: a new method for assessment of platelet dysfunction
3. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
4. Platelet dysfunction in type 2 diabetes
5. Enhanced nitric oxide syntheses in uremic implications for platelet dysfunction and dialysis hypotension
6. Spontaneous spinal epidural hematoma with associated platelet dysfunction from excessive garlic ingestion: a case report.
7. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction
8. Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment
9. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass
10. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis
11. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome
12. Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice
13. Use of DDAVP in inherited and acquired platelet dysfunction
14. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin
15. Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia: a novel cause of acquired qualitative platelet dysfunction.
16. Platelet dysfunction associated with cardiopulmonary bypass
17. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders.
18. Platelet dysfunction in renal failure
19. Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass
20. Haemorrhage, platelet dysfunction and other coagulation defects in uraemia
21. Congenital disorders associated with platelet dysfunction
22. Platelet dysfunction and coagulopathy in intraventricular hemorrhage in the premature infant
23. Effect of chitosan on lingual hemostasis in rabbits with platelet dysfunction induced by epoprostenol
24. Indomethacin disposition and indomethacin-induced platelet dysfunction in premature infants
25. Sodium valproate, platelet dysfunction, and bleeding
26. Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin
27. Newborn platelet dysfunction: a storage pool and release defect.
28. The PFA‐100®: a potential rapid screening tool for the assessment of platelet dysfunction
29. HEMATOLOGY: ISSUES IN THE DIALYSIS PATIENT: Platelet Dysfunction and End‐Stage Renal Disease
30. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial.
31. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction.
32. Effect of drug-induced platelet dysfunction on surgical bleeding
33. Platelet dysfunction after intravenous ketorolac or propacetamol
34. Platelet dysfunction: a new dimension in inflammatory bowel disease.
35. Platelet dysfunction in preleukemic states and in various types of leukemia
36. Acute megakaryoblastic leukaemia associated with intrinsic platelet dysfunction and constitutional ring 21 chromosome in a young boy
37. Platelet dysfunction during cardiopulmonary bypass surgery with special reference to platelet membrane glycoproteins
38. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
39. Fibrinogen fragments and platelet dysfunction in uremia
40. Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 (R) platelet function analyzer
41. Tyrosine kinase inhibitor–induced platelet dysfunction in patients with chronic myeloid leukemia
42. Heparin-induced platelet dysfunction and cardiopulmonary bypass
43. Infusion of sodium nitroprusside induces platelet dysfunction in vitro
44. Platelet dysfunction—differentiation of a newly recognized primary type from that produced by aspirin
45. Platelet dysfunction associated with Wilms tumor and hyaluronic acid
46. Deficient lipoxin synthesis: a novel platelet dysfunction in myeloproliferative disorders with special reference to blastic crisis of chronic myelogenous leukemia
47. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass
48. Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass
49. Intermediate syndrome of platelet dysfunction
50. Acquired platelet dysfunction following mithramycin therapy
51. Platelet dysfunction in lean women with polycystic ovary syndrome and association with insulin sensitivity
52. Platelet dysfunction associated with experimental acute canine ehrlichiosis
53. Correction of platelet dysfunction and bleeding in cyanotic congenital heart disease by simple red cell volume reduction
54. Platelet dysfunction in glycogen storage disease type I
55. Uremic platelet dysfunction: past and present.
56. Platelet dysfunction in the neonate with essential fatty acid deficiency
57. The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates
58. Platelet dysfunction in migraine: effect of self-medication with aspirin.
59. Bleeding disorders due to platelet dysfunction
60. Platelet dysfunction in central obesity
61. Inherited human cPLA2α deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction
62. Beta-lactam antibiotic-induced platelet dysfunction: evidence for irreversible inhibition of platelet activation in vitro and in vivo after prolonged exposure to penicillin
63. X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis
64. A comparison of Plateletworks™ and platelet aggregometry for the assessment of aspirin-related platelet dysfunction in cardiac surgical patients
65. Platelet ultrastructural morphometry for diagnosis of partial delta-storage pool disease in patients with mild platelet dysfunction and/or thrombocytopenia of unknown …
66. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100
67. Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: insights …
68. Platelet dysfunction in outpatients with left ventricular assist devices
69. Platelet dysfunction in vincristine treated patients
70. … of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of …
71. How platelets work: platelet function and dysfunction
72. Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs.
73. Platelet dysfunction and alteration of prostaglandin metabolism after chronic alcohol consumption
74. Platelet dysfunction in patients with severe traumatic brain injury
75. Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: a pilot clinical study
76. A fatal myeloproliferative syndrome in a family with thrombocytopenia and platelet dysfunction
77. Whole blood multiple electrode aggregometry is a reliable point-of-care test of aspirin-induced platelet dysfunction
78. Laboratory evaluation of platelet dysfunction.
79. Acquired platelet dysfunction may be an aetiologic factor in Heyde's syndrome–normalization of bleeding time after aortic valve replacement
80. Platelet dysfunction during Bothrops jararaca snake envenomation in rabbits
81. Glutathione reductase deficiency and platelet dysfunction induced by 1, 3-bis (2-chloroethyl)-1-nitrosourea.
82. Severe platelet dysfunction in a patient with autoantibodies against membrane glycoproteins IIb-IIIa
83. Nafcillin-induced platelet dysfunction and bleeding.
84. Delayed platelet dysfunction in prolonged induced canine hypothermia
85. Platelet dysfunction and a high bone mass phenotype in a murine model of platelet-type von Willebrand disease
86. Platelet Dysfunction Associated With Immune‐Mediated Thrombocytopenia in Dogs
87. Platelet dysfunction (Glanzmann's thrombasthenia) in horses
88. Platelet dysfunction detected at high shear in patients with heart valve disease
89. Severe platelet dysfunction in hairy cell leukemia with improvement after splenectomy
90. Platelet Dysfunction in Homozygous β-Thalassemia
91. Molecular and biochemical basis for the platelet dysfunction in myeloproliferative disorders
92. Tissue-type plasminogen activator and fibrin monomers synergistically cause platelet dysfunction during retransfusion of shed blood after cardiopulmonary bypass
93. Acquired platelet dysfunction
94. Deletion of the C-terminal region of dengue virus nonstructural protein 1 (NS1) abolishes anti-NS1-mediated platelet dysfunction and bleeding tendency
95. Platelet to Leukocyte Adherence Phenomena Platelet Satellitism and Phagocytosis by Neutrophils Associated with in vitro Platelet Dysfunction
96. Cyclic platelet dysfunction in IgE-mediated allergy
97. Platelet Dysfunction in Patients with Vitamin B< sub> 12 Deficiency
98. Platelet dysfunction in myeloproliferative syndromes
99. Platelet dysfunction associated with abdominal aortic aneurysm.
100. Platelet dysfunction in asphyxiated newborn piglets resuscitated with 21% and 100% oxygen
101. Penicillin induced human platelet dysfunction and its reversal by epinephrine
102. Risk of excessive bleeding associated with marginally low von Willebrand factor and mild platelet dysfunction
103. Platelet dysfunction in cardiopulmonary bypass: an experimental comparative study between a centrifugal and a new pulsatile pump.
104. Platelet dysfunction in myelodysplastic syndromes: a clinicopathological study
105. Platelet dysfunction contributes to the haemostatic defect in haemorrhagic fever with renal syndrome
106. Do patients with epistaxis have drug‐induced platelet dysfunction?
107. Factor XIII deficiency associated with Klippel-Weber disease, platelet dysfunction and cryofibrinogenemia
108. Acquired platelet dysfunction with eosinophilia: review of seven adult cases.
109. Dominant inheritance of a novel integrin β3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families
110. Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery
111. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction: a scanning electron microscope study
112. The contribution of anticoagulants to platelet dysfunction with extracorporeal circulation.
113. Conjunctival bleeding in Osler's disease with associated platelet dysfunction: a case report
114. Prevention of platelet dysfunction by vitamin E in diabetic atherosclerosis
115. Prevalent platelet dysfunction in patients with aortic valve disease.
116. Lipolysis generates platelet dysfunction after in vivo heparin administration
117. Platelet dysfunction in Chediak-Higashi syndrome-affected cattle.
118. Acquired platelet dysfunction with eosinophilia.
119. The association of non-small-cell lung cancer, focal segmental glomerulosclerosis, and platelet dysfunction
120. Platelet dysfunction during cardiopulmonary bypass assessed by a novel whole-blood aggregometer
121. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction
122. Effects of desmopressin on thrombogenesis in aspirin‐induced platelet dysfunction
123. Platelet dysfunction associated with clozapine therapy
124. Is platelet adhesion assay able to quantify drug-induced platelet dysfunction?
125. A trial of recombinant alpha 2 interferon in the myelodysplastic syndrome: II. Characterization and response of granulocyte and platelet dysfunction.
126. Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction
127. Platelet signal transduction defect with Gα subunit dysfunction and diminished Gαq in a patient with abnormal platelet responses
128. Platelet dysfunction in acute type A aortic dissection evaluated by the laser light-scattering method
129. Platelet dysfunction in Noonan's syndrome. A case with a platelet cyclooxygenase-like deficiency and chronic idiopathic thrombocytopenic purpura.
130. Psychogenic purpura, idiopathic thrombocytopenic purpura, and platelet dysfunction in the same patient.
131. Familial spastic ataxia associated with Ehlers-Danlos syndrome with platelet dysfunction.
132. Comparison between nasal and intravenous desmopressin for the treatment of aminosalicylic acid-induced platelet dysfunction
133. Effects of DDAVP administrated subcutaneously in dogs with aspirin-induced platelet dysfunction and hemostatic impairment due to chronic liver diseases.
134. Eosinophilic purpura--the syndrome of acquired platelet dysfunction with eosinophilia--a tropical phenomenon.
135. Acquired platelet dysfunction with eosinophilia in white children
136. Familial exudative vitreoretinopathy (FEVR) and platelet dysfunction.
137. Platelet dysfunction associated with insulin therapy in patients with type 2 diabetes: please do not throw the baby out with the bathwater!
138. The use of hydrogen peroxide for achieving dermal hemostasis after burn excision in a patient with platelet dysfunction
139. Platelet dysfunction and its life span in uremia
140. Venous air embolism induces both platelet dysfunction and thrombocytopenia
141. Acquired platelet dysfunction with eosinophilia in children in the south of Thailand
142. Qualitative platelet dysfunction following cancer chemotherapy: a case report
143. Platelet dysfunction in acute megakaryoblastic leukemia
144. Heparin bleeding, platelet dysfunction, and aspirin
145. Platelet dysfunction in malaria
146. Platelet Dysfunction: An Important Factor in Massive Bleeding From Stress Ulcer
147. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.
148. The laboratory evaluation of platelet dysfunction
149. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature
150. Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency
151. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects
152. In vivo platelet retention in human bleeding-time wounds. I. Normal subjects and patients with platelet dysfunction.
153. Platelet dysfunction after normothermic cardiopulmonary bypass in children: Effect of high-dose aprotinin
154. Platelet dysfunction after association with Anaplasma phagocytophilum in vitro
155. Platelet Function Analyzer (PFA-100®) Offers Higher Sensitivity and Specificity than Thromboelastography (TEG®) in Detection of Platelet Dysfunction
156. Conjugated estrogen for platelet dysfunction associated with liver disease
157. Concomitant defect in internal release and influx of calcium in patients with congenital platelet dysfunction and impaired agonist-induced calcium mobilization: …
158. Petechiae due to drug-induced platelet dysfunction
159. … -Papier der DGKL-Arbeitsgruppe “Hämostaseologische Labordiagnostik”/Bleeding Tendency: Strategy for the clarification of platelet dysfunction. Consensus paper of …
160. Hemostatic protein polymer sheath: improvement in hemostasis at percutaneous biopsy in the setting of platelet dysfunction.
161. Platelet Dysfunction in Nutritional Vitamin B12 Deficiency
162. Ataxia telangiectasia with thrombasthenia, platelet dysfunction, and a chromosomal translocation A monoclonal defect?
163. Platelet Dysfunction (Thrombocytopathy) in Extrahepatic Biliary Obstruction
164. Aspirin, prostaglandin E< sub> 1 and Quin-2 AM-induced platelet dysfunction: Restoration of function by noradrenalin
165. Gastrointestinal angiodysplasia in congenital platelet dysfunction
166. The role of antibiotics in platelet dysfunction and coagulopathy.
167. Acquired platelet dysfunction with eosinophilia
168. Acquired platelet dysfunction with eosinophilia (APDE)
169. Sodium valproate, platelet dysfunction and bleeding (author's transl)].
170. Chromosome 22q11. 2 deletion presenting with immune-mediated cytopenias, macrothrombocytopenia and platelet dysfunction
171. Severity of platelet dysfunction induced by prophylactic indomethacin in the premature
172. Platelet dysfunction in acute megakaryoblastic leukemia.
173. Vascular pathology. A study of some blood parameters indicative of leukocyte activation and platelet dysfunction].
174. Purpura due to aspirin-induced platelet dysfunction aggravated by drinking alcohol
175. The effect of long term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients
176. 250 INDOMETHACIN DISPOSITION IN PREMATURE INFANTS: BLEEDING DUE TO PLATELET DYSFUNCTION AFTER SINGLE DOSES OF INDOMETHACIN
177. Heparin bleeding due to qualitative platelet dysfunction.
178. PLATELET DYSFUNCTION–EOSINOPHILIA SYNDROME IN PARASITIZED VENEZUELAN CHILDREN
179. Platelet dysfunction induced by herbal supplements in a patient with mild hemophilia A
180. The endothelial-platelet dysfunction in preeclampsia
181. A case of acquired platelet dysfunction with eosinophilia
182. Alternatives to platelet transfusions in the management of platelet dysfunction or thrombocytopenia
183. Platelet dysfunction
184. Case Report Acquired Platelet Dysfunction with Eosinophilia: Report of Two Cases
185. Platelet dysfunction during extracorporeal membrane oxygenation: A new mechanism by which to control bleeding?
186. Immunoglobulins in acquired platelet dysfunction with eosinophilia.
187. Platelet dysfunction as the presenting feature of atypical myelodysplastic syndrome with monosomy 7, normal blood counts and no bleeding tendency
188. Platelet Dysfunction and Increased Bleeding Tendency in McCune-Albright Syndrome
189. Platelet dysfunction and inhibition of multiple electrode platelet aggregometry caused by penicillin
190. Platelet dysfunction in intraparenchymal hemorrhage
191. Analysis of platelet shape change, inositol metabolism, and Ca mobilization in patients with platelet dysfunction].
192. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients
193. Acquired Platelet Dysfunction in 109 Patients From a Tertiary Care Referral Hospital
194. Platelet dysfunction and stroke in the female migraineur
195. Diagnosis and treatment of pregnancy induced platelet dysfunction
196. Detection of antibiotic-induced platelet dysfunction in whole blood using flow cytometry
197. Sodium Nitroprusside: Does It Cause Platelet Dysfunction in Humans?
198. Iatrogenic Platelet Dysfunction: An Emerging Peril
199. An Update on the Platelet Dysfunction in Chronic Myeloproliferative Syndromes
200. Hemostasis and Platelet Dysfunction in Asphyxiated Neonates
201. Penicillin induced human platelet dysfunction and its reversal by epinephrine
202. Risk of excessive bleeding associated with marginally low von Willebrand factor and mild platelet dysfunction
203. Platelet dysfunction in cardiopulmonary bypass: an experimental comparative study between a centrifugal and a new pulsatile pump.
204. Platelet dysfunction in myelodysplastic syndromes: a clinicopathological study
205. Platelet dysfunction contributes to the haemostatic defect in haemorrhagic fever with renal syndrome
206. Do patients with epistaxis have drug‐induced platelet dysfunction?
207. Factor XIII deficiency associated with Klippel-Weber disease, platelet dysfunction and cryofibrinogenemia
208. Acquired platelet dysfunction with eosinophilia: review of seven adult cases.
209. Dominant inheritance of a novel integrin β3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families
210. Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery
211. Aprotinin prevents cardiopulmonary bypass-induced platelet dysfunction: a scanning electron microscope study
212. The contribution of anticoagulants to platelet dysfunction with extracorporeal circulation.
213. Conjunctival bleeding in Osler's disease with associated platelet dysfunction: a case report
214. Prevention of platelet dysfunction by vitamin E in diabetic atherosclerosis
215. Prevalent platelet dysfunction in patients with aortic valve disease.
216. Lipolysis generates platelet dysfunction after in vivo heparin administration
217. Platelet dysfunction in Chediak-Higashi syndrome-affected cattle.
218. Acquired platelet dysfunction with eosinophilia.
219. The association of non-small-cell lung cancer, focal segmental glomerulosclerosis, and platelet dysfunction
220. Platelet dysfunction during cardiopulmonary bypass assessed by a novel whole-blood aggregometer
221. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction
222. Effects of desmopressin on thrombogenesis in aspirin‐induced platelet dysfunction
223. Platelet dysfunction associated with clozapine therapy
224. Is platelet adhesion assay able to quantify drug-induced platelet dysfunction?
225. A trial of recombinant alpha 2 interferon in the myelodysplastic syndrome: II. Characterization and response of granulocyte and platelet dysfunction.
226. Inherited human gp91phox deficiency is associated with impaired isoprostane formation and platelet dysfunction
227. Platelet signal transduction defect with Gα subunit dysfunction and diminished Gαq in a patient with abnormal platelet responses
228. Platelet dysfunction in acute type A aortic dissection evaluated by the laser light-scattering method
229. Platelet dysfunction in Noonan's syndrome. A case with a platelet cyclooxygenase-like deficiency and chronic idiopathic thrombocytopenic purpura.
230. Psychogenic purpura, idiopathic thrombocytopenic purpura, and platelet dysfunction in the same patient.
231. Familial spastic ataxia associated with Ehlers-Danlos syndrome with platelet dysfunction.
232. Comparison between nasal and intravenous desmopressin for the treatment of aminosalicylic acid-induced platelet dysfunction
233. Effects of DDAVP administrated subcutaneously in dogs with aspirin-induced platelet dysfunction and hemostatic impairment due to chronic liver diseases.
234. Eosinophilic purpura--the syndrome of acquired platelet dysfunction with eosinophilia--a tropical phenomenon.
235. Acquired platelet dysfunction with eosinophilia in white children
236. Familial exudative vitreoretinopathy (FEVR) and platelet dysfunction.
237. Platelet dysfunction associated with insulin therapy in patients with type 2 diabetes: please do not throw the baby out with the bathwater!
238. The use of hydrogen peroxide for achieving dermal hemostasis after burn excision in a patient with platelet dysfunction
239. Platelet dysfunction and its life span in uremia
240. Venous air embolism induces both platelet dysfunction and thrombocytopenia
241. Acquired platelet dysfunction with eosinophilia in children in the south of Thailand
242. Qualitative platelet dysfunction following cancer chemotherapy: a case report
243. Platelet dysfunction in acute megakaryoblastic leukemia
244. Heparin bleeding, platelet dysfunction, and aspirin
245. Platelet dysfunction in malaria
246. Platelet Dysfunction: An Important Factor in Massive Bleeding From Stress Ulcer
247. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia.
248. The laboratory evaluation of platelet dysfunction
249. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature
250. Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency
251. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects
252. In vivo platelet retention in human bleeding-time wounds. I. Normal subjects and patients with platelet dysfunction.
253. Platelet dysfunction after normothermic cardiopulmonary bypass in children: Effect of high-dose aprotinin
254. Platelet dysfunction after association with Anaplasma phagocytophilum in vitro
255. Platelet Function Analyzer (PFA-100®) Offers Higher Sensitivity and Specificity than Thromboelastography (TEG®) in Detection of Platelet Dysfunction
256. Conjugated estrogen for platelet dysfunction associated with liver disease
257. Concomitant defect in internal release and influx of calcium in patients with congenital platelet dysfunction and impaired agonist-induced calcium mobilization: …
258. Petechiae due to drug-induced platelet dysfunction
259. … -Papier der DGKL-Arbeitsgruppe “Hämostaseologische Labordiagnostik”/Bleeding Tendency: Strategy for the clarification of platelet dysfunction. Consensus paper of …
260. Hemostatic protein polymer sheath: improvement in hemostasis at percutaneous biopsy in the setting of platelet dysfunction.
261. Platelet Dysfunction in Nutritional Vitamin B12 Deficiency
262. Ataxia telangiectasia with thrombasthenia, platelet dysfunction, and a chromosomal translocation A monoclonal defect?
263. Platelet Dysfunction (Thrombocytopathy) in Extrahepatic Biliary Obstruction
264. Aspirin, prostaglandin E< sub> 1 and Quin-2 AM-induced platelet dysfunction: Restoration of function by noradrenalin
265. Gastrointestinal angiodysplasia in congenital platelet dysfunction
266. The role of antibiotics in platelet dysfunction and coagulopathy.
267. Acquired platelet dysfunction with eosinophilia
268. Acquired platelet dysfunction with eosinophilia (APDE)
269. Sodium valproate, platelet dysfunction and bleeding (author's transl)].
270. Chromosome 22q11. 2 deletion presenting with immune-mediated cytopenias, macrothrombocytopenia and platelet dysfunction
271. Severity of platelet dysfunction induced by prophylactic indomethacin in the premature
272. Platelet dysfunction in acute megakaryoblastic leukemia.
273. Vascular pathology. A study of some blood parameters indicative of leukocyte activation and platelet dysfunction].
274. Purpura due to aspirin-induced platelet dysfunction aggravated by drinking alcohol
275. The effect of long term, low-dose tranexamic acid treatment on platelet dysfunction and haemoglobin levels in haemodialysis patients
276. 250 INDOMETHACIN DISPOSITION IN PREMATURE INFANTS: BLEEDING DUE TO PLATELET DYSFUNCTION AFTER SINGLE DOSES OF INDOMETHACIN
277. Heparin bleeding due to qualitative platelet dysfunction.
278. PLATELET DYSFUNCTION–EOSINOPHILIA SYNDROME IN PARASITIZED VENEZUELAN CHILDREN
279. Platelet dysfunction induced by herbal supplements in a patient with mild hemophilia A
280. The endothelial-platelet dysfunction in preeclampsia
281. A case of acquired platelet dysfunction with eosinophilia
282. Alternatives to platelet transfusions in the management of platelet dysfunction or thrombocytopenia
283. Platelet dysfunction
284. Case Report Acquired Platelet Dysfunction with Eosinophilia: Report of Two Cases
285. Platelet dysfunction during extracorporeal membrane oxygenation: A new mechanism by which to control bleeding?
286. Immunoglobulins in acquired platelet dysfunction with eosinophilia.
287. Platelet dysfunction as the presenting feature of atypical myelodysplastic syndrome with monosomy 7, normal blood counts and no bleeding tendency
288. Platelet Dysfunction and Increased Bleeding Tendency in McCune-Albright Syndrome
289. Platelet dysfunction and inhibition of multiple electrode platelet aggregometry caused by penicillin
290. Platelet dysfunction in intraparenchymal hemorrhage
291. Analysis of platelet shape change, inositol metabolism, and Ca mobilization in patients with platelet dysfunction].
292. Desmopressin improves platelet dysfunction measured by in vitro closure time in uremic patients
293. Acquired Platelet Dysfunction in 109 Patients From a Tertiary Care Referral Hospital
294. Platelet dysfunction and stroke in the female migraineur
295. Diagnosis and treatment of pregnancy induced platelet dysfunction
296. Detection of antibiotic-induced platelet dysfunction in whole blood using flow cytometry
297. Sodium Nitroprusside: Does It Cause Platelet Dysfunction in Humans?
298. Iatrogenic Platelet Dysfunction: An Emerging Peril
299. An Update on the Platelet Dysfunction in Chronic Myeloproliferative Syndromes
300. Hemostasis and Platelet Dysfunction in Asphyxiated Neonates